Skip to content

Bristol-Myers Squibb Company

BMY CELG-RI

CIK 0000014272

← back to feed
Revenue (TTM)
$47.18B
−0.2% YoY Q1 Apr 2026
Net Income (TTM)
$8.64B
+178.8% YoY Q1 Apr 2026
EPS Diluted (TTM)
$4.23
+178.5% YoY Q1 Apr 2026
Gross Margin
17.3%
Q1 Apr 2026
Operating Margin
—
Q1 Apr 2026
Net Margin
18.3%
Q1 Apr 2026
Free Cash Flow (TTM)
$7.69B
Q1 Apr 2026
Cash
$9.57B
Q1 Apr 2026
Total Debt
$44.46B
Q1 Apr 2026
Shares Outstanding
2.04B sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings